Böllinger Group took part in a $54.7m round for the electric car developer, which had previously raised money through crowdfunding campaigns.
Author: Callum Cyrus
GoDaddy makes $365m Poynt acquisition
NAB, US Bancorp and Alphabet are set to exit payment processing technology provider Poynt in an acquisition sized at up to $365m.
Wolters Kluwer to put eOriginal on its books
Intel will exit the digital loan documentation software publisher in a $279m all-cash acquisition by Wolters Kluwer.
NetGuardians catches new funding
Swisscom and Sberbank-backed fraud prevention software provider NetGuardians raised $19.2m to take its total funding to more than $33m.
ConsejoSano consents to $17m series B
Tufts Health Plan, DaVita Venture Group, Wanxiang America and Salesforce Ventures helped the multicultural patient engagement platform reach $24m in overall funding.
UK leads in quantum academia-industry ties
The UK moves to second phase of quantum initiative, programme links universities to industries at tech hubs, ‘Ion traps’ alternative to superconductors are a key focus
AI face-off: China battles the US while EU plays catch up
China is benefiting from its government’s focus on artificial intelligence (AI) with unlisted companies having raised RMB203.7m ($30bn) in venture capital since 2016, according to Nikkei Asia Tech and 36kr.
Hibob lets rip with $70m series B
Seek will take a board seat at HR and employee management platform developer Hibob having co-led a round that pushed its total funding to $124m.
Rani reaps $69m in series E funding
Drug release technology developer Rani has now raised $211m in all, from investors including GV, Novartis, Ping An Ventures, KPC, AstraZeneca and Stevanato.
CG Oncology sees its way to $47m
Kissei Pharmaceutical has become the cancer immunotherapy developer’s first corporate investor, in a series D round bringing its overall funding to $93.5m.
Temasek segues into Info Edge fund
Temasek has pumped $51.5m into classified listings operator Info Edge’s debut consumer technology fund, bringing its corpus to almost two thirds of its $100m ceiling.
Samsung lifts German Bionic to $20m series A
Samsung’s Catalyst helped the industrial exoskeleton provider close a series A round that will go to advancing the company’s international expansion.
Does Deerfield have The Cure?
Deerfield Management is putting up $2bn for early-stage life sciences research through to 2030, but what does its involvement mean for its partner universities?
AI and ethics: the challenge of lining up stakeholders
Special report: AI technologies present complex ethical challenges, early hopes for a multilateral governance framework, but delicate balance to avoid hampering innovative AI